secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2026-06-25T20:31:27+00:00
Accession:  0001437749-26-021707
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

AYTU terminates Metadate CD license agreement with Lannett
----------------------------------------------------------

- Mutual termination effective June 23, 2026; certain provisions survive per Termination Agreement.
- AYTU may continue to sell existing inventory and pay royalties until sales cease.
- Metadate CD net revenue for quarter ended March 31, 2026 was $49,000, de minimis.
- Termination Agreement will be filed as exhibit to FY 2026 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000143774926021707/0001437749-26-021707-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000143774926021707/aytu20260624c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-021707

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer